Clinical Trial Update: Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation [NA]

View source ↗

Summary

This clinical trial update reports the safety and performance results of the ARGOS-IO System used during Boston Keratoprosthesis implantation, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemical Burns
• Congenital Aniridia
• Congenital Glaucoma
• Graft-versus-host Disease
• Stevens-johnson Syndrome

Drugs mentioned

• ARGOS-IO System

Snippet

Sponsor: Implandata Ophthalmic Products GmbH | Conditions: Graft vs Host Disease, Congenital Aniridia | NA | Status: COMPLETED | Results posted: 2025-02-27